Physician profile
Marco Cioppi
NPI 1437117603
$20,580.36
in general payments reported to CMS, 2019-2025
34 companies · $3,302 in 2025
The $3,302 reported for 2025 was more than what 79% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $4,410 · 2020: $3,526 · 2021: $3,653 · 2022: $2,403 · 2023: $1,219 · 2024: $2,067 · 2025: $3,302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,188 · Consulting Fee: $1,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,187.72 |
| Consulting Fee | $1,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $11,311.74 | 2019-2025 | Alto Abdominal Stent Graft System, Afx2 Bifurcated Endograft System, Torus Stent Graft System |
| Penumbra, INC. | $1,569.83 | 2022 | |
| Nuvasive, INC. | $1,416.96 | 2019 | |
| Medtronic, INC. | $1,405.05 | 2021-2025 | Hawkone, In.Pact Admiral, Everflex |
| Musculoskeletal Transplant Foundation INC. | $1,225.13 | 2020 | |
| Cook Medical LLC | $806.87 | 2019-2025 | Zenith, Zilver Ptx, Zenith Alpha |
| Silk Road Medical, INC. | $403.97 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $370.76 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Conformable Thoracic Stent Graft, Gore Tag Thoracic Endoprosthesis |
| Kerecis Limited | $281.37 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Shockwave Medical, INC | $240.42 | 2020 | |
| Medtronic Vascular, INC. | $202.00 | 2019-2020 | |
| Inari Medical, INC. | $179.06 | 2022-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Mimedx Group, INC. | $113.74 | 2024-2025 | |
| Smith+Nephew, INC. | $109.30 | 2019-2025 | Oasis, Stravix |
| Lemaitre Vascular, INC. | $104.22 | 2022-2024 | Restoreflow, Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $96.38 | 2020-2025 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Janssen Pharmaceuticals, INC | $94.15 | 2021-2024 | Xarelto |
| Artivion, INC. | $90.68 | 2019-2023 | Photofix Decellularized Bovine Pericardium, Vascular |
| Stryker Corporation | $85.25 | 2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S, Artix Mt |
| Cagent Vascular INC | $72.94 | 2025 | Serrantor |
| Terumo Medical Corporation | $61.06 | 2022-2024 | Azur Cx Detachable, Glidewire |
| Convatec INC. | $44.71 | 2021-2023 | |
| Medela LLC | $41.54 | 2022-2023 | Invia Motion Endure |
| Kci USA, INC. | $40.58 | 2020 | |
| Bolton Medical INC | $35.07 | 2024 | Treo Abdominal Stent-Graft System |
| Baxter Healthcare | $30.08 | 2022-2024 | Preveleak |
| Tactile Systems Technology INC | $25.78 | 2019-2022 | |
| Abbott Laboratories | $24.11 | 2022 | |
| Sirtex Medical INC | $21.10 | 2025 | Sir-Spheres Microspheres |
| Imperative Care, INC | $19.77 | 2024 | Hotshot Controller |
| Pfizer INC. | $16.92 | 2022 | |
| Venclose INC. | $16.61 | 2020 | |
| Ekos Corporation | $12.12 | 2019 | |
| Angiodynamics, INC. | $11.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$1,225.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marco Cioppi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.